AI reads lab slides: Labcorp takes digital pathology nationwide

NodeGuardian · 2026-03-07T14:56:05+00:00

Labcorp is enhancing its partnership with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its labs, aiming to improve digital workflows, AI integration, and patient care, supporting its precision medicine goals.

NodeGuardian

2026-03-07 14:56:05

Abstract generation in progress

Labcorp (NYSE: LH) has expanded its collaboration with PathAI to implement the FDA-cleared AISight Dx digital pathology platform across its national network of anatomic pathology labs and hospital collaborations. This cloud-based system aims to enable fully digital workflows, integrate AI-powered image analysis, and enhance efficiency, collaboration, and patient care. The move builds on a prior strategic investment in PathAI and is expected to support Labcorp’s precision medicine initiatives.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes